Skip to Main Content

Paper Details

Establishment of Patient-Derived Tumor Xenograft Models of Epithelial Ovarian Cancer for Preclinical Evaluation of Novel Therapeutics.
Clin Cancer Res
91
2017
CA125, Epithelial Ovarian Cancer, Luciferized PDX models, Ovarian cancer, PDX, PDX models, PDX) models, PI3K, Patient, Patient-Derived Tumor Xenograft Models, Tumor, derived xenograft, gynecologic malignancy, human, human LINE, human LINE-1, luciferized ovarian, luciferized ovarian PDX models, nonluciferized PDX, ovarian cancer, patient, patients, tumor, tumor cells
Author NameAffiliation
Elena IvanovaDana-Farber Cancer Institute
Elena IvanovaBelfer Center for Applied Cancer Science, Dana-Farber Cancer Institute
Elena IvanovaDana-Farber Cancer Institute
Elena IvanovaBelfer Center for Applied Cancer Science, Dana-Farber Cancer Institute
Colin C PritchardUniversity of Washington
Gerburg M WulfBeth Israel Deaconess Medical Center
Victor E VelculescuThe Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Gordon B MillsThe University of Texas MD Anderson Cancer Center
Joan S BruggeHarvard Medical School
Ronny DrapkinPenn Ovarian Cancer Research Center, University of Pennsylvania
Ronny DrapkinPenn Ovarian Cancer Research Center, University of Pennsylvania
  • 1 - 12

Datasets

Release 1.2